Is Universal Health Realty Income Trust overvalued or undervalued?
As of December 3, 2018, Universal Health Realty Income Trust is considered undervalued with a P/E ratio of 30, an EV to EBITDA of 7.32, a PEG ratio of 1.99, and a high dividend yield of 726.22%, indicating a competitive market position despite recent stock performance lagging behind the S&P 500.
As of 3 December 2018, Universal Health Realty Income Trust has moved from a grade of very expensive to very attractive, indicating a significant shift in its valuation perspective. The company is currently considered undervalued. Key ratios include a P/E ratio of 30, an EV to EBITDA of 7.32, and a PEG ratio of 1.99, which suggest that the stock may be trading at a discount relative to its earnings growth potential.In comparison to its peers, Universal Health Realty Income Trust's P/E ratio is notably higher than Dynex Capital, Inc. at 18.29, but lower than the industry average, indicating a competitive position in the market. Additionally, the company's dividend yield of 726.22% stands out, reinforcing its attractiveness compared to peers like CBL & Associates Properties, Inc. with a P/E of 11.34. Despite recent stock performance lagging behind the S&P 500 over longer periods, the recent 1-month return of 7.92% compared to the S&P 500's 3.83% suggests a positive momentum that could further support its undervalued status.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
